MiNK Therapeutics (NASDAQ:INKT) Stock Quotes, Forecast and News Summary

Q: What sector and industry does MiNK Therapeutics (INKT) operate in?

MiNK Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

MiNK Therapeutics Stock (NASDAQ: INKT) stock price, news, charts, stock research, profile.

Open	-
Close	-
Volume / Avg.	100.00 / 156.54K
Day Range	- - -
52 Wk Range	0.75 - 1.96
Market Cap	$33.87M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	42
Short Interest	0.65%
Days to Cover	2.39

Recent News

Why MiNK Therapeutics Stock Is Up 11% Monday

MiNK Therapeutics shares are trading higher Monday after the clinical-stage biopharmaceutical company announced private placement financing of $5.8 million.

Dylan Berman

Why Byrna Technologies Shares Are Trading Higher By Around 7%? Here Are Other Stocks Moving In Friday's Mid-Day Session

Shares of Byrna Technologies Inc. (NASDAQ: BYRN) rose sharply during Friday’s session after the company reported better-than-expected first-quarter revenue, and announced a CFO transition.

Avi Kapoor

Sacks Parente Golf And 3 Other Stocks Under $2 Insiders Are Buying

The Dow Jones closed higher by more than 300 points on Monday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.

Lisa Levin

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Mar

May

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.3

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

About MiNK Therapeutics Inc

Sector

Health Care

Industry

Biotechnology

MiNK Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing allogeneic...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy MiNK Therapeutics (INKT) stock?

You can purchase shares of MiNK Therapeutics (NASDAQ:INKT) through any online brokerage.

View our list of the best stock brokerages

Who are MiNK Therapeutics (INKT) competitors?

Other companies in MiNK Therapeutics’s space includes: NKGen Biotech (NASDAQ:NKGN), Acurx Pharmaceuticals (NASDAQ:ACXP), Gain Therapeutics (NASDAQ:GANX), Curis (NASDAQ:CRIS) and Immuneering (NASDAQ:IMRX).

What is the target price for MiNK Therapeutics (INKT) stock?

There is no analysis for MiNK Therapeutics.

What is the forecast for MiNK Therapeutics (INKT) stock?

MiNK Therapeutics has a consensus price target of $12.00.

Current stock price for MiNK Therapeutics (INKT)?

The stock price for MiNK Therapeutics (NASDAQ: INKT) is $0.8603 last updated July 19, 2024 at 7:40 PM EDT.

Does MiNK Therapeutics (INKT) pay a dividend?

There are no upcoming dividends for MiNK Therapeutics.

When is MiNK Therapeutics (NASDAQ:INKT) reporting earnings?

MiNK Therapeutics’s Q2 earnings are confirmed for Thursday, August 8, 2024.

Is MiNK Therapeutics (INKT) going to split?

There is no upcoming split for MiNK Therapeutics.

What sector and industry does MiNK Therapeutics (INKT) operate in?

MiNK Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Comments

MiNK Therapeutics

MiNK Therapeutics (INKT) Forecast